GSK Acknowledges Probes Of Staff Bribery In Jordan, Lebanon
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline acknowledged it is investigating units in two more countries for possible compliance violations, these in the Middle East countries of Jordan and Lebanon.